Accounts Receivable, Variable Consideration [Roll Forward] Accounts Receivable, Variable Consideration [Roll Forward] Accounts Receivable, Variable Consideration [Roll Forward] 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Payments of long-term debt Repayments of Long-Term Debt Cover [Abstract] Cover [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect In Process Research and Development In-process research and development In Process Research and Development [Member] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Inventory Deferred Tax Assets, Inventory Income Tax Authority [Domain] Income Tax Jurisdiction [Domain] Respiratory delivery platform Respiratory delivery platform [Member] Respiratory delivery platform [Member] Trading Symbol Trading Symbol Comprehensive (loss) earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Fair value of financial instruments Asset Derivatives Derivative Asset, Subject to Master Netting Arrangement, before Offset Non-NEOs Non-NEOs [Member] Yupelri ® Yupelri ® [Member] Yupelri ® Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Maximum milestone payments Variable Interest Entity, Maximum Milestone Payments Variable Interest Entity, Maximum Milestone Payments 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Disposal Group Name [Domain] Disposal Group Name [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Equity securities, FV-NI, gain (loss) Equity Securities, FV-NI, Gain (Loss) Variable Consideration Category [Domain] Variable Consideration Category [Domain] [Domain] for Variable Consideration Category [Axis] Currency Swap Currency Swap [Member] Vesting Period [Domain] Vesting Period [Domain] [Domain] for Vesting Period [Axis] Partial payment of anticipated tax expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense U.S. State Tax Authority U.S. State Tax Authority [Member] U.S. State Tax Authority [Member] AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Earnings per Share Earnings Per Share, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Issuance of restricted stock, net (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Hedging Relationship [Domain] Hedging Relationship [Domain] 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes Other comprehensive loss, before tax Other comprehensive (loss) earnings, before tax Other Comprehensive Income (Loss), before Tax Award Timing Disclosures [Line Items] 2043 Senior Notes (5.400%) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Net Investment Hedging Net Investment Hedging [Member] Investment, Name [Domain] Investment, Name [Domain] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Tax credit and loss carry-forwards Deferred Tax Assets, Tax Credit Carryforwards Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Amount of fair value in excess of carrying amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Plan Name [Domain] Plan Name [Domain] United States UNITED STATES Inventory, Net [Abstract] Inventory, Net [Abstract] Upfront payments Payments To Acquire Collaborative Agreement Payments To Acquire Collaborative Agreement Other assets Other assets Other Assets, Noncurrent Leases [Abstract] Leases [Abstract] Milestone payment payable upon development and regulatory milestones Business Combination, Contingent Consideration, Liability, Milestone Payment Payable Upon Development And Regulatory Milestones Business Combination, Contingent Consideration, Liability, Milestone Payment Payable Upon Development And Regulatory Milestones Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Corporate bonds Corporate Bond Securities [Member] Operating Segments Operating Segments [Member] North America Segment North America Segment [Member] North America Segment Three Customers Three Customers [Member] Three Customers Receivable Type [Axis] Receivable Type [Axis] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Prepaid expenses Prepaid Expense, Current Award Timing Method Award Timing Method [Text Block] Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Restructuring Type [Axis] Restructuring Type [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Prepaid Expense and Other Assets, Current [Abstract] Prepaid Expense and Other Assets, Current [Abstract] Insider Trading Policies and Procedures [Line Items] Fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Proceeds from sale of assets and subsidiaries Proceeds from Divestiture of Businesses Deferred Base Salary Deferred Base Salary [Member] Deferred Base Salary [Member] Use of Estimates in the Preparation of Financial Statements Use of Estimates, Policy [Policy Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Compensation Amount Outstanding Recovery Compensation Amount Chargebacks Chargebacks [Member] Chargebacks [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Other assets Schedule of Other Assets, Noncurrent [Table Text Block] Litigation accrual Estimated Litigation Liability Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Number of manufacturing sites Number Of Manufacturing Sites Number Of Manufacturing Sites Credit Facility [Domain] Credit Facility [Domain] Goodwill, after amortization expense, before reclassification Goodwill, After Amortization Expense, Before Reclassification Goodwill, After Amortization Expense, Before Reclassification Upjohn Distributor Markets Upjohn Distributor Markets [Member] Upjohn Distributor Markets Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Goodwill Goodwill, net, ending balance Goodwill Measurement input, term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Share repurchase program, authorized amount (in shares) Share Repurchase Program, Authorized, Amount Collaborations [Abstract] Collaborations [Abstract] Collaborations [Abstract] Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Milestone payment payable upon achievement of tiered sales milestones Business Combination, Contingent Consideration, Liability, Milestone Payment Payable Upon Achievement Of Tiered Sales Milestones Business Combination, Contingent Consideration, Liability, Milestone Payment Payable Upon Achievement Of Tiered Sales Milestones Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] Fixed income securities Fixed Income Securities [Member] Stock options Share-Based Payment Arrangement, Option [Member] Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Foreign currency forward contracts Foreign Exchange Forward [Member] Depreciation Depreciation 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Other items, net Proceeds from (Payments for) Other Financing Activities Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Pension Benefits Pension Plan [Member] Income taxes payable Accrued Income Taxes, Current Other U.S. items Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Business Combination [Abstract] Business Combination [Abstract] Business Combination [Abstract] Fair value measurement input, discount rate In Process Research And Development, Fair value Measurement Input, Discount Rate In Process Research And Development, Fair value Measurement Input, Discount Rate Maturities Of Available-for-Sale Debt Securities At Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Award Type [Axis] Award Type [Axis] Deferred tax liabilities, net Deferred Tax Liabilities, Net Net Third Party Sales Classified Based on Geographic Location of Subsidiaries Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Period [Domain] Period [Domain] [Domain] for Period [Axis] Deferred Bonus Deferred Bonus [Member] Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Work in process Inventory, Work in Process, Net of Reserves Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Total liabilities Liabilities Dividends paid per share (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Weighted average exercise price per share, exercisable at period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Common Stock, Par or Stated Value Per Share Ordinary shares, par value (in USD per share) Common Stock, Par or Stated Value Per Share Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Foreign Currencies Foreign Currency Transactions and Translations Policy [Policy Text Block] Revolving Credit Facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Cash and Restricted Cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Impact of foreign currency translation OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax Operating lease liability Operating Lease, Liability, Current Other revenues Revenue Not from Contract with Customer Total Shareholder Return Amount Total Shareholder Return Amount Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Number of molecules Number Of Molecules Number Of Molecules Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Net unrecognized gain and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period Net unrealized gains on marketable securities, net of tax, end of period Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block] Property, plant and equipment, gross Property, Plant and Equipment, Gross Number of shares exercised Number of shares under stock awards, exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Plan settlements and terminations Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Net unrecognized gain (loss) on derivatives in hedging relationships Derivative financial instruments in cash flow hedging relationships Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Other assets Other Assets Intangible Assets and Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Reductions due to expirations of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2026 Senior Notes (3.950%) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Diluted (in shares) Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Other Nonoperating Income (Expense) Other Nonoperating Income (Expense) [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Acquired IPR&D Acquired IPR&D Other Research and Development Expense Total deferred tax assets, gross Deferred Tax Assets, Gross Less: Treasury stock - at cost Treasury stock, beginning balance Treasury stock, ending balance Treasury Stock, Value Collaborative and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] Not subject to market conditions Not Subject to Market Conditions [Member] Not Subject to Market Conditions [Member] Mature within one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Financial Instruments And Risk Management Financial Instruments Disclosure [Text Block] Accrued restructuring Restructuring Reserve, Noncurrent Litigation Case [Axis] Litigation Case [Axis] Business Combinations [Abstract] Business Combinations [Abstract] Changes in carrying amount of goodwill Schedule of Goodwill [Table Text Block] Capitalized software Software and Software Development Costs [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Additions Charged to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Selling, general and administrative Selling, General and Administrative Expense Biocon Biologics Biocon Biologics [Member] Biocon Biologics Total employer contributions Defined Contribution Plan, Cost Amount of common stock shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Document Fiscal Period Focus Document Fiscal Period Focus Invoices confirmed during the year Supplier Finance Program, Obligation, Addition Basic (in shares) Weighted Average Basic Shares Outstanding, Pro Forma 2028 Long-Term Debt, Maturity, Year Four Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Acquisition related costs Business Combination, Acquisition Related Costs All Executive Categories All Executive Categories [Member] Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Balance Sheet Location [Domain] Statement of Financial Position Location, Balance [Domain] Equity Securities Equity securities Equity Securities [Member] Share price (in dollars per share) Business Acquisition, Share Price Gains and Losses on Available-For-Sale Fixed Income Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Equity investments Deferred Tax Liabilities, Equity Method Investments Deferred Tax Liabilities, Equity Method Investments Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Average remaining contractual term for options outstanding, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Assets Assets [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Other comprehensive (loss) earnings, net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Amortization of prior service (credit) cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Document Type Document Type Derivative Contract Type [Domain] Derivative Contract [Domain] Gross to net adjustments: Adjustments To Revenue [Abstract] Adjustments To Revenue Actuarial losses (gains) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Defined contribution plan, maximum annual contribution per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Selling, general and administration Selling, General, And Administrative Expense, Adjusted Selling, General, And Administrative Expense, Adjusted Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Purchase of marketable securities Payments to Acquire Marketable Securities Schedule of Other Assets [Line Items] Schedule of Other Assets [Line Items] Schedule of Other Assets [Line Items] Withholding taxes Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability, Noncurrent Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan [Table] Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] Cost Debt Securities, Available-for-Sale, Amortized Cost Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Net sales Sales [Member] Maximum Maximum [Member] Famy Life Sciences Acquisition Famy Life Sciences Acquisition [Member] Famy Life Sciences Acquisition Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Impairment Goodwill, Impaired, Accumulated Impairment Loss Finite-lived intangible assets, net book value Finite-lived intangible assets, net Finite-Lived Intangible Assets, Net Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Effects of Foreign Exchange Accounts Receivable, Effects of Foreign Exchange Rates Accounts Receivable, Effects of Foreign Exchange Rates Accrued sales allowances Accrued Sales Allowances Accrued Sales Allowances Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) from Litigation Settlement Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2.250% Euro Senior Notes due 2024 (1) 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Range [Axis] Statistical Measurement [Axis] Confirmed obligations outstanding at the beginning of the year Confirmed obligations outstanding at the end of the year Supplier Finance Program, Obligation Supplier Finance Program, Obligation Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Cash dividends paid Payments to Noncontrolling Interests Earnings (loss) before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Equity interest in acquiree, fair value Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value Plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Goodwill, impairment loss Impairment of goodwill Goodwill, Impairment Loss Net assets acquired Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Goodwill Disposal Group, Including Discontinued Operation, Goodwill Oyster Point Pharma Acquisition Oyster Point Pharma Acquisition [Member] Oyster Point Pharma Acquisition Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] MDL Multi District Litigation [Member] Multi District Litigation [Member] Investment, Name [Axis] Investment, Name [Axis] Redemption price, percentage Debt Instrument, Redemption Price, Percentage Diluted (in USD per share) Diluted earnings (loss) per share attributable to Viatris Inc. shareholders (in dollars per share) Earnings Per Share, Diluted Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Earnings before income taxes and noncontrolling interest, United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Trade accounts payable Accounts Payable, Trade Non-contingent payments for product rights Payments for Non-Contingent Consideration for Product Rights, Financing Activities Payments for Non-Contingent Consideration for Product Rights, Financing Activities Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Ownership [Axis] Ownership [Axis] Corporate and other unallocated Corporate costs Corporate costs Retirement Benefits [Abstract] Retirement Benefits [Abstract] Customer [Axis] Customer [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Asset backed securities Asset-Backed Securities [Member] Other Deferred Tax Liabilities, Other Net (loss) earnings Net loss Net (loss) earnings Net (loss) earnings attributable to Viatris Inc. common shareholders Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Gain (loss) on divestiture of business Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory 2.125% Euro Senior Notes due 2025 (3) 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Income tax provision Income tax related to items of other comprehensive (loss) earnings, derivatives Income tax (benefit) provision Income Tax Expense (Benefit) Interest cost Defined Benefit Plan, Interest Cost Earnings (loss) before income taxes and noncontrolling interest: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Notional amount of derivative Derivative, Notional Amount Available-for-sale fixed income securities Debt Securities, Available-for-Sale, Current Returns Variable Consideration Returns [Member] Variable Consideration Returns [Member] Interest rate swap derivative assets Derivative Asset Weighted-average period over which total unrecognized compensation expense expected to be recognized (years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Intangible assets Deferred Tax Assets Intangible Assets Deferred Tax Assets Intangible Assets Net sales Net sales Revenue from Contract with Customer, Excluding Assessed Tax Commercial Paper Program Commercial Paper Program [Member] Commercial Paper Program [Member] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Number of women's healthcare products sold Number Of Women's Healthcare Products Sold Number Of Women's Healthcare Products Sold Generics Generics [Member] Generics Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Interest expense Interest expense Interest Expense, Operating and Nonoperating Amount of additional common stock shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Income Tax Authority [Axis] Income Tax Jurisdiction [Axis] Business Acquisition [Line Items] Business Acquisition [Line Items] Operating lease liabilities Deferred Tax Liabilities, Operating Lease, Liability Deferred Tax Liabilities, Operating Lease, Liability All Adjustments to Compensation All Adjustments to Compensation [Member] Payroll and employee benefit liabilities Employee-related Liabilities, Current Additional paid-in capital Additional Paid in Capital Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Expected total pre-tax charges for restructuring Charges Restructuring Charges Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Rebates, promotional programs and other sales allowances Rebates, Promotional Programs and Other Sales Allowances [Member] Rebates, Promotional Programs and Other Sales Allowances [Member] 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Issuance of restricted stock and stock options exercised, net Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Accounts payable Accounts payable Accounts Payable, Trade, Current Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Impairment of goodwill Goodwill, Impairment Loss, Adjusted Goodwill, Impairment Loss, Adjusted Consideration received on divestiture Disposal Group, Including Discontinued Operation, Consideration Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Amortization of prior service costs included in SG&A Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Financial Instruments [Domain] Financial Instruments [Domain] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Weighted average grant-date fair value per share, nonvested beginning balance Weighted average grant-date fair value per share, nonvested ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Income Tax Examination, Estimate of Possible Loss Income Tax Examination, Estimate of Possible Loss Number of states Number of states Number of states Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Utilization Restructuring and Related Cost, Incurred Cost Contingent consideration Other Liabilities, Fair Value Disclosure Restatement Determination Date Restatement Determination Date Number of shares under stock awards, vested and expected to vest at period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Accounts receivable allowances Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Governmental rebate programs Governmental Rebate Programs [Member] Governmental Rebate Programs [Member] Additions Charged to Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Accrued interest and penalties Income Tax Examination, Penalties and Interest Accrued Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Cardinal Health Inc Cardinal Health Inc [Member] Cardinal Health Inc [Member] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Weightedaverage exercise price per share, outstanding at beginning of period Weighted average exercise price per share, outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use assets Right-of-use asset Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of shares under stock awards, outstanding at beginning of period Number of shares under stock awards, outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Other noncurrent liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Anticompetitive Conduct with Generic Drugs Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Subject to Market Conditions [Domain] Subject to Market Conditions [Domain] [Domain] for Subject to Market Conditions [Axis] Other Long Term Debt Other Long Term Debt [Member] Other long term debt. Subsequent Event Subsequent Event [Member] Research credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Restricted cash, included in prepaid expenses and other current assets Restricted Cash and Cash Equivalents, Current Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Gain (loss) on investments Gain (Loss) on Investments Weighted average grant-date fair value per share, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Restructuring Plan [Axis] Restructuring Plan [Axis] Other Other Debt Obligations [Member] Segments [Domain] Segments [Domain] Income tax provision (benefit) Other Comprehensive Income (Loss), Tax Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Unrecognized Tax Benefits [Roll Forward] Manufacturing and supply agreements, period Collaborative Arrangement, Rights and Obligations, Manufacturing And Supply Agreements, Period Collaborative Arrangement, Rights and Obligations, Manufacturing And Supply Agreements, Period Private Equity Securities Private Equity Securities [Member] Private Equity Securities Commitments Commitments Disclosure [Text Block] PEO PEO [Member] Confirmed invoices paid during the year Supplier Finance Program, Obligation, Settlement Name Trading Arrangement, Individual Name Funded status of plans Defined Benefit Plan, Funded (Unfunded) Status of Plan 2016 through 2035 Future years [Member] Future years [Member] Product rights and licenses by therapeutic category Product Rights And Licenses By Therapeutic Category [Table Text Block] Product rights and licenses by therapeutic category Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Gains and Losses on Derivatives in Cash Flow Hedging Relationships Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Total Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Entity Public Float Entity Public Float Disposal Group Name [Axis] Disposal Group Name [Axis] Lyrica ® Lyrica ® [Member] Lyrica ® Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Projected benefit obligation, beginning of year Projected benefit obligation, end of year Defined Benefit Plan, Benefit Obligation Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Operating loss carryforwards expired in period Deferred Tax Asset, Operating Loss Carryforwards, Expired In Period Deferred Tax Asset, Operating Loss Carryforwards, Expired In Period SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Variable Consideration Category [Axis] Variable Consideration Category [Axis] Variable Consideration Category [Axis] Local Phone Number Local Phone Number Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Prepaid expenses & other current assets Prepaid Expenses and Other Current Assets [Member] Valuation allowance, amount Less: Valuation allowance Deferred Tax Assets, Valuation Allowance Zoloft ® Zoloft ® [Member] Zoloft ® 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Total operating expenses Operating Expenses Other Restructuring Other Restructuring [Member] Deferred tax liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Reclassification to assets held for sale Goodwill, Transfers Fair value of financial instruments Liability Derivatives Derivative Liability, Subject to Master Netting Arrangement, before Offset Non marketable equity securities Equity Securities, FV-NI, Cost Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Accrued interest Interest Payable, Current Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Weighted average exercise price per share, vested and expected to vest at period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Subject to Market Conditions Subject to Market Conditions [Member] Subject to Market Conditions Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Other Adjustments to Additional Paid in Capital, Other Common Stock Common Stock [Member] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Line of Credit Line of Credit [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Inventories Schedule of Inventory, Current [Table Text Block] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Fair value loss (gain) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Discontinued Operations and Disposal Groups [Abstract] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Deferred charge for taxes on intercompany profit Deferred Charges, Tax On Intercompany Profit Deferred Charges, Tax On Intercompany Profit Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Current portion of long-term debt and other long-term obligations Long-Term Debt, Current Maturities Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Accretion Accretion Expense Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restricted stock Restricted Stock [Member] Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Interest expense (income) related to uncertain tax positions Income Tax Examination, Interest Expense Title Trading Arrangement, Individual Title Consolidated Entities [Axis] Consolidated Entities [Axis] Total gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Unrecognized tax benefit Unrecognized tax benefit — beginning of year Unrecognized tax benefit — beginning of year Unrecognized tax benefit — end of year Unrecognized Tax Benefits Purchases of IPR&D Proceeds From Refund Of In Process Research And Development Proceeds From Refund Of In Process Research And Development Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Auditor Location Auditor Location Contingent consideration liability Purchase consideration, contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Mature in five years and later Available for Sale Securities Debt Maturities after Five Years and Later Fair Value Available for sale securities debt maturities after five years and later fair value. Disposal Group Classification [Domain] Disposal Group Classification [Domain] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Other (income) expense, net Other Expense [Member] Contingent consideration Contingent Consideration [Member] Contingent Consideration. Variable Consideration Variable Consideration [Member] Variable Consideration [Member] Purchase of ordinary shares Payments for Repurchase of Common Stock 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Valuation allowance for deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Long-term debt Long-Term Debt, Excluding Current Maturities SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Period [Axis] Period [Axis] Period [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Axis] (Loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Equity Equity [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Retained earnings Retained Earnings (Accumulated Deficit) Foreign currency translation Goodwill, Translation and Measurement Period Adjustments Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Inventories Increase (Decrease) in Inventories Supplemental disclosures of cash flow information — Supplemental Cash Flow Elements [Abstract] Impact of foreign currency translation Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Summary of Long-Term Debt Schedule of Debt [Table Text Block] Equity securities, FV-NI, unrealized gain (loss) Equity Securities, FV-NI, Unrealized Gain (Loss) 2026 Long-Term Debt, Maturity, Year Two Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Total lease liability Operating Lease, Liability Underlying Securities Award Underlying Securities Amount Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Performance Shares Performance Shares [Member] Cash dividends declared Dividends, Common Stock, Cash Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-Term Revenue Growth Rate [Member] Amendment Flag Amendment Flag Total Expected Future Benefit Payments Expected Future Benefit Payments Foreign currency translation adjustment Foreign currency translation adjustment, beginning of period Foreign currency translation adjustment, end of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Machinery and equipment Machinery and Equipment [Member] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Governmental rebate programs Medicaid and other governmental rebates Medicaid and other governmental rebates Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Face amount Debt Instrument, Face Amount Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Cross-currency interest rate swaps Interest Rate Swap [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Net Accrued Benefit Costs Classification on Balance Sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Rate used to discount net cash inflows to present values Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input IPR&D intangible asset impairment charges Intangible asset (including IPR&D) disposal & impairment charges Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Auditor Name Auditor Name Weighted average grant-date fair value per share, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Gain (loss) on extinguishment of debt Gain (Loss) on Extinguishment of Debt Other current liabilities Other Current Liabilities [Member] Fiscal Year 2017 Fiscal Year 2017 [Member] Fiscal Year 2017 [Member] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Deferred income tax benefit Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Opiod Civil Litigation Opiod Civil Litigation [Member] Opiod Civil Litigation Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Property, plant and equipment, estimated service life (years) Property, Plant and Equipment, Useful Life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Accounts receivable in factoring arrangement Transfers of Financial Assets Accounted for as Sale, Initial Fair Value of Assets Obtained as Proceeds Net accrued benefit costs Net accrued benefit costs Net accrued benefit costs Total intangible asset amortization expense (including disposal & impairment charges) Amortization Designated as hedging instrument Designated as Hedging Instrument [Member] Net earnings attributable to Mylan N.V. ordinary shareholders Net Income (Loss) Available to Common Stockholders, Basic Impact of the Combination and divestitures Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Impact of foreign currency translation Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Projected benefit obligation Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Total assets Assets Dymista ® Dymista ® [Member] Dymista ® Cost of sales Cost of Goods and Services Sold Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Other long-term obligations Other long-term obligations Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Amended Multi District Litigation Amended Multi District Litigation [Member] Amended Multi District Litigation Statutory Tax Rate to Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Loss contingency accrual Loss Contingency, Damages Paid, Value Net unrealized loss on available-for-sale fixed income securities, net of tax Net unrealized gains on marketable securities, net of tax, beginning of period Net unrealized gains on marketable securities, net of tax, end of period AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax Termination Date Trading Arrangement Termination Date Nature of Operations Nature of Operations [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Agency mortgage-backed securities Collateralized Mortgage-Backed Securities [Member] Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Long-Term Debt, Maturity, Year One Statement of Financial Position Location, Activity, Capitalization [Axis] Statement of Financial Position Location, Activity, Capitalization [Axis] API Business API Business [Member] API Business Equity securities — exchange traded funds Exchange Traded Funds [Member] Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Deferred tax impact of tax law changes Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Mature in one to five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Net Income (Loss) Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Summary of classification and fair values of derivative instruments in consolidated balance sheets Fair Value, by Balance Sheet Grouping [Table Text Block] Thereafter Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Goodwill impairment, measurement input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] 2020 Floating Rate Euro Notes 2020 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Entity File Number Entity File Number Schedule of Assumptions Used Defined Benefit Plan, Assumptions [Table Text Block] Consolidated Entities [Domain] Consolidated Entities [Domain] Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One U.S. Federal Current Current Federal Tax Expense (Benefit) Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Restructuring Plan [Domain] Restructuring Plan [Domain] Remaining lease terms Lessee, Operating Lease, Term of Contract Name Forgone Recovery, Individual Name Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List Not Disclosed, Flag Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List Not Disclosed, Flag Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List Not Disclosed, Flag Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Inventory reserves Inventory Valuation Reserves Other non-cash items Other Noncash Income (Expense) Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Goodwill impairment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent Basic (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Financial or other support, amount Variable Interest Entity, Financial or Other Support, Amount Reductions for prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Long Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Other Pension, Postretirement and Supplemental Plans Other Pension, Postretirement and Supplemental Plans [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Accounts Receivable Accounts Receivable [Member] Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Business Acquisition, Date of Acquisition [Abstract] Business Acquisition, Date of Acquisition [Abstract] Litigation Case [Domain] Litigation Case [Domain] Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss, net of tax, beginning of period Accumulated other comprehensive loss, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Net of Tax In process research and development Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, In Process Research And Development Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, In Process Research And Development Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate Basic (in shares) Weighted average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Number of insulin analog products Number Of Insulin Analog Products Number Of Insulin Analog Products Capitalized software costs Capitalized Computer Software, Net Total equity Balance Balance Total equity Equity, Including Portion Attributable to Noncontrolling Interest Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Name Awards Close in Time to MNPI Disclosures, Individual Name Construction in progress Construction in Progress [Member] Third party net sales Revenue Benchmark [Member] Cost of sales Cost Of Goods And Services Sold, Adjusted Cost Of Goods And Services Sold, Adjusted Number of shares under stock awards, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Entity Filer Category Entity Filer Category Shares issued (in shares) Balance (in shares) Balance (in shares) Shares, Issued Loss Contingencies [Line Items] Loss Contingencies [Line Items] Xalabrands Xalabrands [Member] Xalabrands Accrued restructuring Restructuring Reserve, Current Acquisitions Goodwill, Acquired During Period Range [Domain] Statistical Measurement [Domain] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Lease, Cost Lease, Cost [Table Text Block] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Available-for-sale fixed income investments Available-for-sale fixed income investments Debt Securities [Member] Other current liabilities Other current liabilities Other Liabilities, Current Unrecognized tax benefits that impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Earnings Per Common Share Attributable To Mylan Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Stock option award vesting period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Credit carryforward Tax Credit Carryforward, Amount Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Derivative [Line Items] Derivative [Line Items] Assets held for sale Disposal Group, Including Discontinued Operation, Assets [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Other Commitments [Line Items] Other Commitments [Line Items] Reduction due to acquisition Unrecognized Tax Benefits, Decrease Resulting from Acquisition Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Segment profit Gross Profit, Adjusted Gross Profit, Adjusted Derivative [Table] Derivative [Table] Income Tax Contingency [Table] Income Tax Contingency [Table] Divestitures Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Viagra ® Viagra ® [Member] Viagra ® Other Performance Measure, Amount Other Performance Measure, Amount Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Accumulated benefit obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Litigation Legal Matters and Contingencies [Text Block] Goodwill [Line Items] Goodwill [Line Items] Leases Lessee, Operating Leases [Text Block] Net unrealized (loss) gain on available-for-sale fixed income securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Income tax provision (benefit), Non-U.S. Foreign Income Tax Expense (Benefit), Continuing Operations Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Other current liabilities Other Receivables, Net, Current Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Axis] Derivative asset, de-designated notional amount Derivative Asset, De-Designated Notional Amount Derivative Asset, De-Designated Notional Amount Operating lease liability Operating Lease, Liability, Noncurrent Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Cash flow hedging relationships Cash Flow Hedging [Member] Intangible assets, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Income tax provision (benefit), U.S. Federal Federal Income Tax Expense (Benefit), Continuing Operations Swedish Tax Authorities (STA) Swedish Tax Authorities (STA) [Member] Swedish Tax Authorities (STA) Service cost Defined Benefit Plan, Service Cost EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Entity Tax Identification Number Entity Tax Identification Number Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Additions for prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Common stock repurchase (in shares) Treasury Stock, Shares, Acquired Ministry of Finance, India Ministry of Finance, India [Member] Impact of foreign currency translation Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Non-U.S. Deferred Deferred Foreign Income Tax Expense (Benefit) Retirement Plan Type [Axis] Retirement Plan Type [Axis] Defined benefit plan, ultimate health care cost trend rate, projected Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Money market funds Money Market Funds [Member] Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Patents Patents [Member] Treasury Stock Treasury Stock, Common [Member] Deferred tax assets: Deferred Tax Assets, Net [Abstract] U.S. Treasuries US Treasury Securities [Member] Decrease in contingent milestone payments Business Combination, Contingent Consideration, Liability, Contingent Milestone Payment Payable Business Combination, Contingent Consideration, Liability, Contingent Milestone Payment Payable Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Plan Name [Axis] Plan Name [Axis] Income tax receivable Income Taxes Receivable Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Research and Development and Acquired IPR&D Research and Development Expense, Policy [Policy Text Block] Fair Value Debt Securities, Available-for-Sale Net earnings Business Acquisition, Pro Forma Net Income (Loss) Contingent consideration paid Disposal Group, Including Discontinued Operations, Contingent Consideration Paid Disposal Group, Including Discontinued Operations, Contingent Consideration Paid Notional amount of derivative Derivative Asset, Notional Amount Unrecognized actuarial net gain Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Other comprehensive (loss) earnings, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Receivable [Domain] Receivable [Domain] Women's Healthcare Business Women's Healthcare Business [Member] Women's Healthcare Business Reconciliation of segment profit: Segment Reconciliation [Abstract] Participant contributions DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation Defined Benefit Plan Contributions By Plan Participants Benefit Obligation Intellectual Property Developed Technology Rights [Member] Geographical [Axis] Geographical [Axis] Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] 2029 Lessee, Operating Lease, Liability, to be Paid, Year Five Loss (gain) on disposal of business Loss (gain) on disposal of business Gain (Loss) on Disposition of Business Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Accounts receivable, net Receivables, Net, Current Shares repurchased during the period Stock Repurchased During Period, Value Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability, Current Interest expense Deferred Tax Assets, Deferred tax expense, interest expense Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense. Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Disaggregation of Revenue, Variable Consideration Disaggregation of Revenue, Variable Consideration [Table Text Block] Disaggregation of Revenue, Variable Consideration Loss contingency accrual Loss Contingency Accrual Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Unrecognized prior service cost (credit) Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Cash payment Payments for Restructuring Japan, Austalia and New Zealand Segment Japan, Austalia and New Zealand Segment [Member] Japan, Austalia and New Zealand Segment Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total unrecognized compensation expense, net of estimated forfeitures Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Indefinite Indefinite [Member] Indefinite amount of time Unrecognized actuarial (gain) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Non-U.S. Current Current Foreign Tax Expense (Benefit) Current assets: Assets, Current [Abstract] Consolidation Items [Axis] Consolidation Items [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Treasury stock (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Expected Long-term Return on Assets Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrecognized gains (losses) on derivatives, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Product and Service [Domain] Product and Service [Domain] Allowance for doubtful accounts SEC Schedule, 12-09, Allowance, Credit Loss [Member] Summary of notional amounts of net investment hedges Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Weighted average grant-date fair value per share, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Security Exchange Name Security Exchange Name Number of cases Number of cases Number of cases Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Theravance Biopharma Theravance Biopharma [Member] Theravance Biopharma Litigation reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Weighted average exercise price per share, exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] U.S. State Current Current State and Local Tax Expense (Benefit) Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Stockholders Equity Parent Before Treasury Stock Stockholders Equity Parent Before Treasury Stock Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock. Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and development expense Research and Development Expense Recognition of tax carryforwards Effective Income Tax Rate Reconciliation, Operating Loss Carryforward Expired In Period, Percent Effective Income Tax Rate Reconciliation, Operating Loss Carryforward Expired In Period, Percent Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] AmeriSourceBergen Corporation AmeriSourceBergen Corporation [Member] AmeriSourceBergen Corporation Amortization of actuarial loss included in SG&A Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Rebates, promotional programs and other sales allowances Rebates, Promotional Programs And Other Sales Allowances Rebates, Promotional Programs And Other Sales Allowances Income taxes Increase (Decrease) in Income Taxes Payable Deferred consideration due from Biocon Biologics Disposal Group, Including Discontinued Operation, Deferred Consideration Due Disposal Group, Including Discontinued Operation, Deferred Consideration Due Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Concentration risk, percentage Concentration Risk, Percentage Expected foreign tax credits Deferred Tax Assets, Tax Credit Carryforwards, Foreign Assets held for sale Total assets held for sale Disposal Group, Including Discontinued Operation, Assets Twenty Twenty Four Revolving Facility Twenty Twenty Four Revolving Facility [Member] Twenty Twenty Four Revolving Facility Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Plans with Accumulated Benefit Obligation in Excess of Plan Assets Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] 2025 Euro Senior Notes 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Divestitures Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan Current Provision Related to Sales Made in the Current Period Accounts Receivable, Sales Provisions, Current Accounts Receivable, Sales Provisions, Current Ordinary shares, number of shares authorized (in shares) Common Stock, Shares Authorized Cash paid for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Plan settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Citalopram Litigation Citalopram Litigation [Member] Citalopram Litigation Entity Voluntary Filers Entity Voluntary Filers Amortization of actuarial gain Defined Benefit Plan, Amortization of Gain (Loss) Hedging Designation [Domain] Hedging Designation [Domain] Balance Sheet Location [Axis] Statement of Financial Position Location, Balance [Axis] Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense Deferred income tax benefit Deferred Income Tax Expense (Benefit) Litigation settlement, expected loss Litigation Settlement, Expected Loss Litigation Settlement, Expected Loss Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Debt, Current Debt, Current Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Accounts receivable, net Beginning of period End of period Total Accounts Receivable, after Allowance for Credit Loss, Current Influvac ® Influvac ® [Member] Influvac ® Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] U.S. Federal Tax Authority U.S. Federal Tax Authority [Member] U.S. Federal Tax Authority [Member] Total impairment charge Asset Impairment Charges Derivative financial instruments not designated as hedging instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Long-term debt Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Fair value of plan assets, beginning of year Fair value of plan assets, end of year Fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Thereafter Long-Term Debt, Maturity, after Year Five Other current liabilities Disposal Group, Including Discontinued Operation, Liabilities, Current Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Plant Divestitures Plant Divestitures [Member] Plant Divestitures Leverage ratio Debt Instrument, Restrictive Covenants, Leverage Ratio Debt Instrument, Restrictive Covenants, Leverage Ratio Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Acquired IPR&D Payments to Acquire in Process Research and Development Deferred cash consideration Divestiture of Business, Deferred Cash Consideration. Divestiture of Business, Deferred Cash Consideration. Document Annual Report Document Annual Report Unrecognized prior service cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Number of restricted stock awards, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Amount of operating leases not yet commenced Lessee, Operating Lease, Lease Not yet Commenced, Amount Lessee, Operating Lease, Lease Not yet Commenced, Amount Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Intangible asset amortization expense Intangible asset amortization expense Amortization of Intangible Assets Deferred consideration received Disposal Group, Including Discontinued Operation, Deferred Consideration Received Disposal Group, Including Discontinued Operation, Deferred Consideration Received Payments of financing fees Payments of Financing Costs SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Other Foreign Operations Non-US [Member] Convertible Preferred Stock Convertible Preferred Stock [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Liabilities Liabilities [Abstract] Revenues: Revenues [Abstract] Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Allowances for doubtful accounts Beginning balance Ending balance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount PEO Name PEO Name Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Award Type [Domain] Award Type [Domain] Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Cash acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Product rights and licenses Licensing Agreements [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Noncurrent liabilities Liability, Defined Benefit Plan, Noncurrent Deferred income tax benefit Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Finite-lived intangible asset, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Additional Paid-In Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Other assets Disposal Group, Including Discontinued Operation, Other Assets Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Collaborative Arrangement Collaborative Arrangement [Member] Employee Benefits Retirement Benefits [Text Block] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Type of Restructuring [Domain] Type of Restructuring [Domain] Income taxes Income Taxes Paid Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Contingent consideration payments Payments of Merger Related Costs, Financing Activities Employee Severance Employee Severance [Member] CHINA CHINA Restructuring and Related Activities Disclosure Restructuring and Related Activities Disclosure [Text Block] Rate used to discount net cash inflows to present values Business Combination, Contingent Consideration, Liability, Measurement Input Schedule of Revenue by Major Customers by Reporting Segments Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Defined Pension Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Inventories Disposal Group, Including Discontinued Operation, Inventory Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Corporate (Other) Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Other long-term obligations Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Cash paid during the period for: Supplemental Cash Flow Information [Abstract] Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets Equity securities Equity Securities, FV-NI Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Effect of Derivative Instruments on the Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Income tax provision (benefit), U.S. State State and Local Income Tax Expense (Benefit), Continuing Operations Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] 2046 Senior Notes (5.250%) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule II - Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Auditor Firm ID Auditor Firm ID Effective tax rate Effective tax rate Effective Income Tax Rate Reconciliation, Percent Deferred income tax benefit Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Earnings (loss) from operations Earnings from operations Operating Income (Loss) Inventories Inventories [Member] McKesson Corporation McKesson Corporation [Member] McKesson Corporation [Member] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Number of reportable segments Number of Reportable Segments Total liabilities and equity Liabilities and Equity Early repayment of senior debt Early Repayment of Senior Debt Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Debt and Equity Securities Marketable Securities, Policy [Policy Text Block] Acquired IPR&D Payments To Acquire In Process Research And Development, Other Payments To Acquire In Process Research And Development, Other Hedging Designation [Axis] Hedging Designation [Axis] Equity consideration Noncash or Part Noncash Divestiture, Amount of Consideration Received Derecognized accounts receivables Proceeds from Sale and Collection of Receivables Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Ownership percentage Disposal Group, Including Discontinued Operation, Ownership Percentage In Disposed Asset Disposal Group, Including Discontinued Operation, Ownership Percentage In Disposed Asset Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Transition services, period Collaborative Arrangement, Rights and Obligations, Transition Services, Period Collaborative Arrangement, Rights and Obligations, Transition Services, Period Underlying Security Market Price Change Underlying Security Market Price Change, Percent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Measurement Input Type [Axis] Measurement Input Type [Axis] Individual: Individual [Axis] Buildings and improvements Building and Building Improvements [Member] Taxes related to the net share settlement of equity awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Weighted average exercise price per share, forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Inventories Inventories Inventory, Net Creon ® Creon ® [Member] Creon ® Liabilities held for sale Total liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Product and Service [Axis] Product and Service [Axis] Accounting Policies [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Famy Life Sciences Famy Life Sciences [Member] Famy Life Sciences Other payables Accounts Payable, Other Operating expenses: Operating Expenses [Abstract] Defined Benefit Plan, Plan Assets, Benefits Paid Defined Benefit Plan, Plan Assets, Benefits Paid Property, plant and equipment, net Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Acquisition purchase price Business Combination, Consideration Transferred Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Current portion of long-term debt Current Portion of Long-Term Debt [Member] Derivatives Derivatives, Policy [Policy Text Block] 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Minimum Minimum [Member] Unamortized Debt Issuance Expense Unamortized Debt Issuance Expense Contingent liability (up to) Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. [Member] Oyster Point Pharma, Inc. Adoption Date Trading Arrangement Adoption Date OTC Business OTC Business [Member] OTC Business Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Tax Period [Axis] Tax Period [Axis] Total revenues Business Acquisition, Pro Forma Revenue Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Derivative Instrument [Axis] Derivative Instrument [Axis] Prepaid expenses and other current assets Schedule of Other Current Assets [Table Text Block] Other Income Other Income [Member] Total Long-Term Debt, Gross Exercise Price Award Exercise Price Write down-to fair value, less costs to sell Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down Developed Markets Developed Markets Segment [Member] Developed Markets Segment Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Defined benefit plan, ultimate health care cost trend rate Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Arrangement Duration Trading Arrangement Duration Celebrex ® Celebrex ® [Member] Celebrex ® Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Deferred tax impact of internal restructuring Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent Net operating loss carryforwards Operating Loss Carryforwards 2028 Senior Notes 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Change in unrecognized (loss) gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Net change Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Viatris Inc. shareholders’ equity Equity, Attributable to Parent [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Trade accounts payable Increase (Decrease) in Accounts Payable, Trade 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Price of acquisition, expected Business Combination, Price of Acquisition, Expected Credit Concentration Risk Credit Concentration Risk [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Fair value of long-term debt Debt Instrument, Fair Value Disclosure Other expense (income), net Other nonoperating income (expense) Other Nonoperating Income (Expense) Other Postretirement Benefits Other Postretirement Benefits Plan [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Non-cash charges mainly related to accelerated depreciation and asset impairment charges Restructuring Reserve, Settled without Cash Plan curtailment, settlement and termination Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Acquisition Disposal Group, Including Discontinued Operations, Contingent Consideration Increase (Decrease) Disposal Group, Including Discontinued Operations, Contingent Consideration Increase (Decrease) Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Change in Plan Assets Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Women's Health Products Women's Health Products [Member] Women's Health Products Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Current liabilities Liability, Defined Benefit Plan, Current Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Diluted (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Percentage of fair value in excess of carrying amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Liability Class [Axis] Liability Class [Axis] Deferred income tax liability Deferred Income Tax Liabilities, Net YEN Term Loan YEN Term Loan [Member] YEN Term Loan Interest expense Interest Expense [Member] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Shares repurchased during the period (in shares) Stock Repurchased During Period, Shares Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Chargebacks Chargebacks Chargebacks Identified intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles U.S. Federal Deferred Deferred Federal Income Tax Expense (Benefit) Other current liabilities Schedule of Accrued Liabilities [Table Text Block] Marketable Securities Marketable Securities [Member] Marketable Securities Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Impairment of intangible assets Intangible asset disposal & impairment charges Impairment of Intangible Assets, Finite-Lived Projected benefit obligation, beginning of year Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Measure: Measure [Axis] Additions for current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Asset Class [Domain] Asset Class [Domain] Issuance of common stock to Mylan N.V. shareholders (in shares) Stock Issued During Period, Shares, New Issues 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year One Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Number of shares under stock awards, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Initial accounting incomplete, adjustment, inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Total liabilities at recurring fair value measurement Liabilities, Fair Value Disclosure 2029 Long-Term Debt, Maturity, Year Five Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Valuation allowance on assets held for sale Disposal Group, Including Discontinued Operations, Deferred Tax Assets, Valuation Allowance Disposal Group, Including Discontinued Operations, Deferred Tax Assets, Valuation Allowance Accounts payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Australian Taxation Office Australian Taxation Office [Member] Equity Component [Domain] Equity Component [Domain] Divestitures Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan Incremental U.S. tax on foreign earnings Effective Income Tax Rate Reconciliation, GILTI, Percent Other long-term assets Other long-term assets Other long-term assets Product Rights And Licenses Product Rights And Licenses [Member] Product Rights And Licenses Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2028 Defined Benefit Plan, Expected Future Benefit Payment, Year Four SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Statement [Table] Accounting Policies [Table] Statement [Table] Counterparty Name [Axis] Counterparty Name [Axis] Summary Of Significant Accounting Policies Significant Accounting Policies [Text Block] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Consolidation Items [Domain] Consolidation Items [Domain] Xanax ® Xanax ® [Member] Xanax ® Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Approximate expected severance and employee benefit expense Restructuring and Related Cost, Expected Cost Remaining Level 1 Fair Value, Inputs, Level 1 [Member] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior Notes Senior Notes Senior Notes [Member] Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Tax settlements and resolution of certain tax positions Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Tax Period [Domain] Tax Period [Domain] Number of shares under stock awards, exercisable at period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number 2027 Long-Term Debt, Maturity, Year Three Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Company contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Income Taxes Income Tax Disclosure [Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent Current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Goodwill, derecognized Goodwill, Derecognized Goodwill, Derecognized Securitized accounts receivable Accounts Receivable from Securitization Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Supplier Finance Program Supplier Finance Program [Table Text Block] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Short-Term Borrowings Debt, Policy [Policy Text Block] Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Change in short-term borrowings, net Proceeds from (Repayments of) Short-Term Debt Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] [Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class Credit Facility [Axis] Credit Facility [Axis] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Entity Registrant Name Entity Registrant Name Amitiza ® Amitiza ® [Member] Amitiza ® Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Gross profit Gross Profit Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] U.S. State Deferred Deferred State and Local Income Tax Expense (Benefit) Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Noncurrent assets Assets for Plan Benefits, Defined Benefit Plan Level 2 Fair Value, Inputs, Level 2 [Member] Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Geographical [Domain] Geographical [Domain] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Property, plant and equipment, net Disposal Group, Including Discontinued Operation, Intangible Assets Issuance of common stock Stock Issued During Period, Value, New Issues Diluted (in shares) Pro Forma Weighted Average Shares Outstanding, Diluted Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Principles of Consolidation Consolidation, Policy [Policy Text Block] Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Assets held by insurance companies and other Assets held by insurance companies and other [Member] Assets held by insurance companies and other [Member] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,234,131,491 as of December 31, 2024 and 1,221,994,491 as of December 31, 2023 Common Stock, Value, Issued Document Financial Statement Error Correction Document Financial Statement Error Correction [Flag] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Payment Arrangement [Abstract] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Issuance of common stock Stock Issued During Period, Value, Acquisitions Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Issuance of common stock (in shares) Stock Issued During Period, Shares, Acquisitions Other Deferred Tax Assets, Other Intangible Assets Excluding Goodwill [Line Items] Finite-Lived Intangible Assets [Line Items] Non-U.S. state tax authority Non-U.S. state tax authority [Member] Non-U.S. state tax authority [Member] Land and improvements Land and Land Improvements [Member] API API [Member] API Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] 2029 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Lipitor ® Lipitor ® [Member] Lipitor ® Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total deferred tax liabilities Deferred Tax Liabilities, Gross Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Basic (in USD per share) Basic earnings (loss) per share attributable to Viatris Inc. shareholders (in dollars per share) Earnings Per Share, Basic Issuance of common stock Proceeds from Issuance of Common Stock Cash and cash equivalents Cash and Cash Equivalents [Member] Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Stock option award expiration period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Ownership [Domain] Ownership [Domain] Other Foreign Operations Other [Member] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Schedule of Goodwill [Table] Goodwill [Table] Disposal Group, Held-for-sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Intangible assets and goodwill Deferred Tax Liabilities, Intangible Assets Brands Brands [Member] Brands Total current liabilities Liabilities, Current Vest after three years Vest in three years or less [Member] Vest in three years or less Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Number of restricted stock awards, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Payments for rent Payments for Rent Operating lease assets Deferred Tax Assets, Operating Lease, Right-of-Use Assets Deferred Tax Assets, Operating Lease, Right-of-Use Assets Other Other Sundry Liabilities, Noncurrent Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract] Contingent Consideration Business Combinations Policy [Policy Text Block] Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Total revenues Revenues Revenues Share-Based Incentive Plan Share-Based Payment Arrangement [Text Block] Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Amended Anticompetitive Conduct with Generic Drugs Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Entity Address, City or Town Entity Address, City or Town Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Stock Awards Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Lexicon Lexicon [Member] Lexicon Divestitures Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Other Commitments [Table] Other Commitments [Table] Weighted average exercise price per share, granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Number of restricted stock awards, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Business Acquisition [Axis] Business Acquisition [Axis] Components of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Product Liability Product Liability [Member] Product Liability Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Foreign Foreign Tax Authority Foreign Tax Jurisdiction [Member] Europe Segment Europe Segment [Member] Europe Segment Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Effexor ® Effexor ® [Member] Effexor ® Common stock repurchase Treasury Stock, Value, Acquired, Cost Method Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Total assets at recurring fair value measurement Assets, Fair Value Disclosure Other Other Accrued Liabilities, Current Audit Information [Abstract] Audit Information Earnings before income taxes and noncontrolling interest, foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Statement of Financial Position Location, Activity, Capitalization [Domain] Statement of Financial Position Location, Activity, Capitalization [Domain] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Period End Date Document Period End Date Norvasc ® Norvasc ® [Member] Norvasc ® Finished goods Inventory, Finished Goods, Net of Reserves Total lease payments Lessee, Operating Lease, Liability, to be Paid Number of restricted stock awards, nonvested beginning balance Number of restricted stock awards, nonvested ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Checks/ Credits Issued to Third Parties Accounts Receivable, Credits Issued to Third Parties Accounts Receivable, Credits Issued to Third Parties Asset Class [Axis] Asset Class [Axis] Insider Trading Arrangements [Line Items] Gain (loss) on disposition of stock in subsidiary or equity method investee Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Business Combination, Fair Value, In Process Research And Development, Measurement Input Business Combination, Fair Value, In Process Research And Development, Measurement Input Business Combination, Fair Value, In Process Research And Development, Measurement Input Segment Reconciling Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Deferred income tax liability Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Other Current Assets Other Current Assets [Member] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Viatris Inc. Viatris Inc. [Member] Viatris Inc. Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Amount of unrecognized deferred tax liability Increase in Unrecognized Tax Benefits is Reasonably Possible Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Foreign currency option and forward contracts Foreign Exchange Contract [Member] Document Transition Report Document Transition Report Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Idorsia Pharmaceuticals Ltd. Idorsia Pharmaceuticals Ltd. [Member] Idorsia Pharmaceuticals Ltd. Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] State income taxes and credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Customer [Domain] Customer [Domain] Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Other long-term obligations Other Noncurrent Liabilities [Table Text Block] Ownership percentage by noncontrolling owners Subsidiary, Ownership Percentage, Noncontrolling Owner Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Restricted Stock Awards Restricted Stock Units (RSUs) [Member] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Supplier Finance Program, Obligation [Roll Forward] Supplier Finance Program, Obligation [Roll Forward] Executive Category: Executive Category [Axis] Mapi Pharma Ltd. Mapi Pharma Ltd. [Member] Mapi Pharma Ltd. Medium-term Notes Medium-Term Note [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other PUERTO RICO PUERTO RICO Schedule of Components of Income Tax Provision Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Restructuring Reserve, Beginning Balance Restructuring Reserve, Ending Balance Restructuring Reserve Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] Transaction related and other special items Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Company Selected Measure Name Company Selected Measure Name 2048 Senior Notes 2048 Senior Notes [Member] 2048 Senior Notes [Member]